SynthesisHypertension research : official journal of the Japanese Society of Hypertension2019
Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses.
Synthesis in Hypertension research : official journal of the Japanese Society of Hypertension, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.Archivos de cardiologia de Mexico · 2022Guideline
- Hypertriglyceridemic waist phenotype and 10-year incidence of hypertension: Yazd healthy heart cohort study.ARYA atherosclerosis · 2026Article
- Blood Pressure Control and Maintenance in U.S. Veterans: Roles of Sex, Race, Ethnicity, and Deprivation.JACC. Advances · 2025Article
- Trends and projections of hypertensive heart disease burden in China: a comprehensive analysis from 1990 to 2030.BMC public health · 2025Article
- Management of Hypertension in the Asia-Pacific Region: A Structured Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024Review
- A tryst of 'blood pressure control- sex- comorbidities': the odyssey of basic public health services in Yunnan in quest for truth.BMC public health · 2024Article
- Gender Difference of Blood Pressure Control Rate and Clinical Prognosis in Patients With Resistant Hypertension: Real-World Observation Study.Journal of Korean medical science · 2023Article
- Stroke in Women: A Review Focused on Epidemiology, Risk Factors, and Outcomes.Journal of stroke · 2023Review
- Ethnicity Disparities in the Prevalence, Awareness, Treatment, and Control Rates of Hypertension in China.International journal of hypertension · 2023Article
- Article
- The Burden of Resistant Hypertension Across the World.Current hypertension reports · 2022Review
- Measuring Knowledge, Attitudes, and Barriers to Medication Adherence in Potential Bariatric Surgery Patients.Obesity surgery · 2021Article
- Gender differences and determinants of prevalence, awareness, treatment and control of hypertension among adults in China and Sweden.BMC public health · 2020Article
- Sex differences in the association between major risk factors and the risk of stroke in the UK Biobank cohort study.Neurology · 2020Article
- Association of hemoglobin glycation index and its interaction with obesity/family history of hypertension on hypertension risk: a community-based cross-sectional survey.BMC cardiovascular disorders · 2020Article
- Article
- Elevated glycosylated hemoglobin levels and their interactive effects on hypertension risk in nondiabetic Chinese population: a cross-sectional survey.BMC cardiovascular disorders · 2020Article
- Self-reported diet management, dietary quality, and blood pressure control in Korean adults with hypertension.Clinical hypertension · 2019Article
- Disease Burden of Chronic Kidney Disease in China (1990-2021): An Analysis for the Global Burden of Disease Study 2021.Kidney diseases (Basel, Switzerland)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Hypertension is the major cause of preventable disease burden in China. However, limited evidence is available on sex differences in the awareness, treatment, and control of hypertension. We assessed sex differences in the awareness, treatment, and control of hypertension in China. A systematic search of four English language and four Chinese-language databases was conducted to identify studies conducted from 2005 that reported sex-specific data on the awareness, treatment, and control of hypertension in China. Random-effects meta-analysis weighted by the inverse of the variances were used to obtain pooled sex-specific rates and women-minus-men differences, and their 95% confidence intervals (CI). Overall, 57 studies comprising 2,155,829 individuals (55% women) were included. Awareness (53% in women vs. 47% in men), treatment among all (44% vs. 38%), treatment among aware (65% vs. 60%), control among all (17% vs. 14%), and control among treated (27% vs. 27%) were low for both sexes, but more favourable in women than men. The corresponding women-minus men difference was 7% (95% CI: 6; 8%) for awareness, 6% (5; 8%) for treatment among all, 6% (2; 9%) for treatment among aware, 3% (2; 3%) for control among all, and 0% (-2; 1%) for control among treated. Awareness, treatment, and control of hypertension in China is low in both sexes, but greater in women than men. Sex-specific interventions may be needed to efficiently combat the burden of hypertension.
Indexed as
Identifiers
30518984What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.